Literature DB >> 15880525

Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis.

Karin Jennbacken1, Christina Vallbo, Wanzhong Wang, Jan-Erik Damber.   

Abstract

BACKGROUND: Vascular endothelial growth factor C (VEGF-C) and its receptor, VEGFR-3, have been implicated as important factors in the formation of lymphatic vessels and recent evidence suggests that tumor lymphangiogenesis promotes lymphatic metastasis.
METHODS: The expression of VEGF-C and VEGFR-3 was examined in 22 human prostate cancer specimens with immunohistochemistry. A semi-quantitative scoring system was used for evaluation of staining.
RESULTS: Expression of VEGF-C was stronger in prostate cancer areas in comparison to adjacent benign glands. In addition, patients with lymph node metastases had a significantly higher expression of VEGF-C than patients without lymph node metastases. Interestingly, VEGFR-3 was expressed in malignant prostate epithelial cells and its expression was significantly higher in the lymph node positive group compared to the lymph node negative group.
CONCLUSIONS: The results of the present study indicate that increased expression of VEGF-C and VEGFR-3 play a role in prostate cancer progression and in metastasis to regional lymph nodes. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15880525     DOI: 10.1002/pros.20276

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  51 in total

1.  High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.

Authors:  Kerry Byrnes; Stephen White; Quyen Chu; Carol Meschonat; Herbert Yu; Lester W Johnson; Arrigo Debenedetti; Fleurette Abreo; Richard H Turnage; John C McDonald; Benjamin D Li
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

2.  Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.

Authors:  Michael H Muders; Heyu Zhang; Enfeng Wang; Donald J Tindall; Kaustubh Datta
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

3.  VEGF-C-VEGFR3/Flt4 axis regulates mammary tumor growth and metastasis in an autocrine manner.

Authors:  Michelle L Varney; Rakesh K Singh
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

4.  Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance.

Authors:  Marissa J Stanton; Samikshan Dutta; Heyu Zhang; Navatha S Polavaram; Alexey A Leontovich; Pia Hönscheid; Frank A Sinicrope; Donald J Tindall; Michael H Muders; Kaustubh Datta
Journal:  Cancer Res       Date:  2012-11-13       Impact factor: 12.701

Review 5.  Cell survival signaling in neuroblastoma.

Authors:  Michael L Megison; Lauren A Gillory; Elizabeth A Beierle
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

6.  Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells.

Authors:  Masaki Matsuura; Mitsuho Onimaru; Yoshikazu Yonemitsu; Hanako Suzuki; Toshiaki Nakano; Hiroaki Ishibashi; Kanemitsu Shirasuna; Katsuo Sueishi
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

7.  Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Jerry E Stewart; Michael Megison; William G Cance; Elena V Kurenova
Journal:  Mol Carcinog       Date:  2012-10-12       Impact factor: 4.784

8.  Study on relationship between angiogenesis and micrometastases of peripheral blood in breast cancer.

Authors:  Xiao-Dong Xie; Shu-Xian Qu; Zhao-Zhe Liu; Fang Zhang; Zhen-Dong Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-30       Impact factor: 4.553

9.  Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.

Authors:  Jeremy B Burton; Saul J Priceman; James L Sung; Ebba Brakenhielm; Dong Sung An; Bronislaw Pytowski; Kari Alitalo; Lily Wu
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

10.  Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.

Authors:  Johanna Tuomela; Maija Valta; Jani Seppänen; Kati Tarkkonen; H Kalervo Väänänen; Pirkko Härkönen
Journal:  BMC Cancer       Date:  2009-10-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.